Report Detail

Pharma & Healthcare United States Influenza A Virus, H3N2 Subtype Infections Drug Market Report 2018

  • RnM1684922
  • |
  • 8 March, 2018
  • |
  • Global
  • |
  • 107 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    United States Influenza A Virus, H3N2 Subtype Infections Drug Market Report 2018

      1 Influenza A Virus, H3N2 Subtype Infections Drug Overview

      • 1.1 Product Overview and Scope of Influenza A Virus, H3N2 Subtype Infections Drug
      • 1.2 Classification of Influenza A Virus, H3N2 Subtype Infections Drug by Product Category
        • 1.2.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
        • 1.2.2 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
        • 1.2.3 NEO-8877
        • 1.2.4 NP-025
        • 1.2.5 NSC-61610
        • 1.2.6 NVINF-1
        • 1.2.7 Others
      • 1.3 United States Influenza A Virus, H3N2 Subtype Infections Drug Market by Application/End Users
        • 1.3.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 Others
      • 1.4 United States Influenza A Virus, H3N2 Subtype Infections Drug Market by Region
        • 1.4.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Value) Comparison by Region (2013-2025)
        • 1.4.2 The West Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2013-2025)
        • 1.4.3 Southwest Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2013-2025)
        • 1.4.4 The Middle Atlantic Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2013-2025)
        • 1.4.5 New England Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2013-2025)
        • 1.4.6 The South Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2013-2025)
        • 1.4.7 The Midwest Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2013-2025)
      • 1.5 United States Market Size (Value and Volume) of Influenza A Virus, H3N2 Subtype Infections Drug (2013-2025)
        • 1.5.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales and Growth Rate (2013-2025)
        • 1.5.2 United States Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2013-2025)

      2 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Competition by Players/Suppliers

      • 2.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
      • 2.2 United States Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Share by Players/Suppliers (2013-2018)
      • 2.3 United States Influenza A Virus, H3N2 Subtype Infections Drug Average Price by Players/Suppliers (2013-2018)
      • 2.4 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Competitive Situation and Trends
        • 2.4.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Concentration Rate
        • 2.4.2 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Share of Top 3 and Top 5 Players/Suppliers
        • 2.4.3 Mergers & Acquisitions, Expansion in United States Market
      • 2.5 United States Players/Suppliers Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Base Distribution, Sales Area, Product Type

      3 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales (Volume) and Revenue (Value) by Region (2013-2018)

      • 3.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales and Market Share by Region (2013-2018)
      • 3.2 United States Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Market Share by Region (2013-2018)
      • 3.3 United States Influenza A Virus, H3N2 Subtype Infections Drug Price by Region (2013-2018)

      4 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

      • 4.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales and Market Share by Type (Product Category) (2013-2018)
      • 4.2 United States Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Market Share by Type (2013-2018)
      • 4.3 United States Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2013-2018)
      • 4.4 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate by Type (2013-2018)

      5 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales (Volume) by Application (2013-2018)

      • 5.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales and Market Share by Application (2013-2018)
      • 5.2 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate by Application (2013-2018)
      • 5.3 Market Drivers and Opportunities

      6 United States Influenza A Virus, H3N2 Subtype Infections Drug Players/Suppliers Profiles and Sales Data

      • 6.1 AbbVie Inc
        • 6.1.1 Company Basic Information, Manufacturing Base and Competitors
        • 6.1.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.1.2.1 Product A
          • 6.1.2.2 Product B
        • 6.1.3 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.1.4 Main Business/Business Overview
      • 6.2 AIMM Therapeutics B.V.
        • 6.2.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.2.2.1 Product A
          • 6.2.2.2 Product B
        • 6.2.3 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.2.4 Main Business/Business Overview
      • 6.3 Aphios Corporation
        • 6.3.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.3.2.1 Product A
          • 6.3.2.2 Product B
        • 6.3.3 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.3.4 Main Business/Business Overview
      • 6.4 Celltrion, Inc.
        • 6.4.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.4.2.1 Product A
          • 6.4.2.2 Product B
        • 6.4.3 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.4.4 Main Business/Business Overview
      • 6.5 FluGen, Inc.
        • 6.5.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.5.2.1 Product A
          • 6.5.2.2 Product B
        • 6.5.3 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.5.4 Main Business/Business Overview
      • 6.6 Glide Pharmaceutical Technologies Limited
        • 6.6.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.6.2.1 Product A
          • 6.6.2.2 Product B
        • 6.6.3 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.6.4 Main Business/Business Overview
      • 6.7 ILiAD Biotechnologies, LLC
        • 6.7.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.7.2.1 Product A
          • 6.7.2.2 Product B
        • 6.7.3 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.7.4 Main Business/Business Overview
      • 6.8 Inovio Pharmaceuticals, Inc.
        • 6.8.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.8.2.1 Product A
          • 6.8.2.2 Product B
        • 6.8.3 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.8.4 Main Business/Business Overview
      • 6.9 Johnson & Johnson
        • 6.9.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.9.2.1 Product A
          • 6.9.2.2 Product B
        • 6.9.3 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.9.4 Main Business/Business Overview
      • 6.10 Medicago Inc.
        • 6.10.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Category, Application and Specification
          • 6.10.2.1 Product A
          • 6.10.2.2 Product B
        • 6.10.3 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        • 6.10.4 Main Business/Business Overview
      • 6.11 MedImmune, LLC
      • 6.12 Mucosis B.V.
      • 6.13 NanoViricides, Inc.
      • 6.14 OPKO Health, Inc.
      • 6.15 Sarepta Therapeutics, Inc.
      • 6.16 VBI Vaccines Inc.
      • 6.17 Visterra, Inc.
      • 6.18 Zydus Cadila Healthcare Limited

      7 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Cost Analysis

      • 7.1 Influenza A Virus, H3N2 Subtype Infections Drug Key Raw Materials Analysis
        • 7.1.1 Key Raw Materials
        • 7.1.2 Price Trend of Key Raw Materials
        • 7.1.3 Key Suppliers of Raw Materials
        • 7.1.4 Market Concentration Rate of Raw Materials
      • 7.2 Proportion of Manufacturing Cost Structure
        • 7.2.1 Raw Materials
        • 7.2.2 Labor Cost
        • 7.2.3 Manufacturing Expenses
      • 7.3 Manufacturing Process Analysis of Influenza A Virus, H3N2 Subtype Infections Drug

      8 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 8.1 Influenza A Virus, H3N2 Subtype Infections Drug Industrial Chain Analysis
      • 8.2 Upstream Raw Materials Sourcing
      • 8.3 Raw Materials Sources of Influenza A Virus, H3N2 Subtype Infections Drug Major Manufacturers in 2017
      • 8.4 Downstream Buyers

      9 Marketing Strategy Analysis, Distributors/Traders

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
        • 9.1.3 Marketing Channel Development Trend
      • 9.2 Market Positioning
        • 9.2.1 Pricing Strategy
        • 9.2.2 Brand Strategy
        • 9.2.3 Target Client
      • 9.3 Distributors/Traders List

      10 Market Effect Factors Analysis

      • 10.1 Technology Progress/Risk
        • 10.1.1 Substitutes Threat
        • 10.1.2 Technology Progress in Related Industry
      • 10.2 Consumer Needs/Customer Preference Change
      • 10.3 Economic/Political Environmental Change

      11 United States Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Value and Volume) Forecast (2018-2025)

      • 11.1 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales Volume, Revenue Forecast (2018-2025)
      • 11.2 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales Volume Forecast by Type (2018-2025)
      • 11.3 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales Volume Forecast by Application (2018-2025)
      • 11.4 United States Influenza A Virus, H3N2 Subtype Infections Drug Sales Volume Forecast by Region (2018-2025)

      12 Research Findings and Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources

        In this report, the United States Influenza A Virus, H3N2 Subtype Infections Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

        Geographically, this report splits the United States market into seven regions:
        The West
        Southwest
        The Middle Atlantic
        New England
        The South
        The Midwest
        with sales (volume), revenue (value), market share and growth rate of Influenza A Virus, H3N2 Subtype Infections Drug in these regions, from 2013 to 2025 (forecast).

        United States Influenza A Virus, H3N2 Subtype Infections Drug market competition by top manufacturers/players, with Influenza A Virus, H3N2 Subtype Infections Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
        AbbVie Inc
        AIMM Therapeutics B.V.
        Aphios Corporation
        Celltrion, Inc.
        FluGen, Inc.
        Glide Pharmaceutical Technologies Limited
        ILiAD Biotechnologies, LLC
        Inovio Pharmaceuticals, Inc.
        Johnson & Johnson
        Medicago Inc.
        MedImmune, LLC
        Mucosis B.V.
        NanoViricides, Inc.
        OPKO Health, Inc.
        Sarepta Therapeutics, Inc.
        VBI Vaccines Inc.
        Visterra, Inc.
        Zydus Cadila Healthcare Limited

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        NEO-8877
        NP-025
        NSC-61610
        NVINF-1
        Others
        On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
        Clinic
        Hospital
        Others

        If you have any special requirements, please let us know and we will offer you the report as you want.



        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,800.00
        $7,600.00
        2,698.00
        5,396.00
        3,131.20
        6,262.40
        418,342.00
        836,684.00
        278,996.00
        557,992.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report